2019 Symposium on Research Development in Dry Age-Related Macular Degeneration
Topic: 2019 Symposium on Research Development in Dry Age-Related [...]
SB05PC (EndoTAG®-1) Phase III been Approved in China by NMPA
China NMPA Approves SynCore Biotechnology to Conduct Phase III [...]
2019 INTERNATIONAL PANCREATIC CANCER FORUM
Event Datetime 2019.07.27 (Sat) 1:30-5:20 pm (GMT+8) Event [...]
Pancreatic Cancer: FOLFIRINOX Experience Sharing
Event Datetime 2019.03.16 (Sat) 13:00-14:40 (GMT+8) Event Location [...]
SynCore Bio Enrolled First Patient In Phase III Trial for SB05 Pancreatic Cancer in Hungary
Taipei, Taiwan, 14 January 2019. SynCore Biotechnology Co. (4192:TT) announces [...]